Internal Medicine, Pulmonary Disease · Naples, FL
NPI
1891780490
Since 2005
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
6
Medicare group memberships
Hospitals
2
Hospital affiliations
400 8th St N
Naples, FL, 34102
Phone (239) 263-8385
Groups this clinician bills Medicare through
Medicare paid, 2024
$124K
2,348 services
Medicare patients, 2024
702
Average age 78
Drug cost, 2024
$1.0M
1,626 prescriptions
Company payments, 2025
$2,764
From 23 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Marc D Laufe was code 99213 (office e&m - established), 538 times for 403 patients. In total Marc D Laufe billed 2,348 services in 31 codes, and Medicare paid $124K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-02-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 538 | 403 | $66.34 | $36K |
| 96160 E&M - Miscellaneous | Office | 416 | 274 | $2.09 | $869 |
| 99214 Office E&M - Established | Office | 374 | 259 | $91.27 | $34K |
| 99233 Hospital E&M - Subsequent | Facility | 175 | 46 | $93.24 | $16K |
| 94726 Pulmonary Function Testing | Office | 156 | 156 | $11.02 | $1,719 |
| 94729 Pulmonary Function Testing | Office | 156 | 156 | $8.23 | $1,284 |
| 94060 Pulmonary Function Testing | Office | 146 | 146 | $8.50 | $1,240 |
| 99205 Office E&M - New | Office | 85 | 85 | $152.16 | $13K |
| 99231 Hospital E&M - Subsequent | Facility | 64 | 23 | $40.15 | $2,570 |
| 99223 Hospital E&M - Initial | Facility | 49 | 43 | $135.56 | $6,642 |
| 36415 Venipuncture Blood Collection | Office | 23 | 21 | $8.65 | $199 |
| 99221 Hospital E&M - Initial | Facility | 20 | 19 | $67.79 | $1,356 |
| 94618 Pulmonary Function Testing | Office | 19 | 19 | $26.94 | $512 |
| 99091 E&M - Miscellaneous | Office | 18 | 18 | $38.24 | $688 |
| 99215 Office E&M - Established | Office | 16 | 16 | $144.70 | $2,315 |
By year: 2022 $292K for 4,912 services; 2023 $234K for 3,961 services; 2024 $124K for 2,348 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 23 | 21 | $8.65 | $199 |
Medicare prescription drug claims, 2024
In 2024, the drug Marc D Laufe prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 328 prescriptions and refills. In total Marc D Laufe wrote 1,626 Medicare prescriptions that cost $1.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 328 | 742 | 100 | $465K |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 239 | 588 | 74 | $261K |
| Montelukast Sodium Generic | 177 | 510 | 66 | $2,355 |
| Omeprazole Generic | 154 | 439 | 65 | $2,624 |
| Breo Ellipta Fluticasone/Vilanterol | 117 | 236 | 39 | $91K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 112 | 132 | 70 | $2,924 |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 59 | 94 | 16 | $44K |
| Roflumilast Generic | 39 | 93 | 14 | $5,681 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 36 | 72 | 13 | $8,203 |
| Fluticasone Propionate Generic | 31 | 76 | 14 | $1,307 |
| Wixela Inhub Fluticasone Propion/Salmeterol | 24 | 60 | 12 | $3,787 |
| Arnuity Ellipta Fluticasone Furoate | 23 | 33 | Under 11 | $7,620 |
| Zolpidem Tartrate Generic | 21 | 38 | Under 11 | $61.91 |
| Levocetirizine Dihydrochloride Generic | 20 | 58 | Under 11 | $614 |
| Azithromycin Generic | 20 | 23 | 16 | $77.74 |
Brand drugs: 969 claims; generic drugs: 657 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Marc D Laufe $2,764 ($2,764 in general payments such as food, travel and fees) from 23 companies. The largest payer was GlaxoSmithKline, LLC. with $477.
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. GSK | 32 | $477 |
| Verona Pharma, Inc. VRNA | 13 | $358 |
| AstraZeneca Pharmaceuticals LP AZN | 11 | $325 |
| Regeneron Healthcare Solutions, Inc. REGN | 5 | $255 |
| Insmed, Inc. INSM | 16 | $220 |
| Genzyme Corporation SNY | 5 | $165 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 6 | $142 |
| Merck Sharp & Dohme LLC MRK | 5 | $134 |
| Ambu Inc. | 1 | $116 |
| Mallinckrodt Hospital Products Inc. | 4 | $107 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.